MAY 14, 2015 10:30 AM PDT

An unbiased view of the Next Generation Sequencing market

  • CEO, CSO and Co-Founder, AllSeq, Inc.
      Dr. Shawn C. Baker is the Chief Science Officer and co-founder of AllSeq. Having received his Ph.D. at the University of California - Davis, he started his career as a Research Scientist at Illumina when it was a 15-person startup. After spending several years at the bench developing gene expression array products, he transitioned to Product Marketing where he led a team in charge of Illuminas Expression and Regulation sequencing portfolio. In 2013 Dr. Baker co-founded AllSeq, establishing the only true sequencing marketplace, matching researchers with service providers based on their needs.
      <br />


    The next generation sequencing market has been experiencing rapid advancements over the past several years. While this makes for an exciting time in the field of genomics, it can be difficult for researchers to keep up with the latest developments. Through the projects placed on AllSeq's Sequencing Marketplace, which matches researchers with sequencing providers, we have a unique and unbiased look at the market. Analysis of the projects yields insights into the popularity and true cost of the various platforms and applications. An overview of the latest trends will be presented, with special attention given to clinical sequencing.

    Show Resources
    Loading Comments...